A recent study suggests that patients who discontinue new weight-loss injections like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who end traditional lifestyle programs.
Findings released in a prominent health publication shows that while overweight people frequently drop a large proportion of their total mass while on the medication, the mass comes back at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals purchasing these medications should be aware of the potential of rapid weight regain when the therapy concludes," warns researcher Dr. Susan Jebb.
Such speed of regain implies a return to original mass within about a year and a half.
Weighing Approaches
The study, which reviewed dozens of studies involving thousands of participants, compared the outcomes of the injectable medications with other pills.
The team emphasize that people who shed pounds through lifestyle changes alone typically see a slower creep back—approximately 100 grams monthly—after stopping.
Explaining the Rapid Regain
Nutrition scientists propose the mechanism of the injections is key to understanding the amplified rebound.
These medications copy a body's own chemical called GLP-1, which moderates hunger.
"Sustained high doses of the hormone levels several times higher than normal might result in the system to produce less of its own natural hormone, and may also lessen sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this hormone supplement means appetite is uncontrolled, making excessive eating much more probable."
An Ongoing Condition?
The NHS suggest the injections for people with obesity-related medical conditions, alongside recommended lifestyle changes.
A number of clinicians say that, given the significant potential of relapse, the therapy should be considered life-long.
This opinion is echoed by pharmaceutical companies, who say that the findings "emphasize the long-term nature of obesity," comparing it to managing conditions like high blood pressure.
User Testimonies
Users who have stopped the medication explain a intense resurgence of hunger.
"It was like a switch activating and I was suddenly starving," recalled a patient.
This challenge is compounded if individuals have not established permanent dietary or behavioural modifications during therapy.
Growing Interest
Survey data suggest that millions of people in the UK have used these injections in the past year, with demand remaining high.
- Use is more common among females compared to men.
- The 40s and 50s demographic shows the greatest level of interest.
- Many obtain the medications through private prescriptions rather than the NHS.
Finally, clinicians emphasize that while these medications are potent agents for weight loss, they are not a standalone cure and maintained weight loss hinges on integrated behavioural management.
